Navigating the wait: study tests whether a guide can speed up breast cancer diagnosis

NCT ID NCT05181722

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether having a patient navigator—a person who helps guide you through the healthcare system—can help women get timely follow-up care after an abnormal mammogram. The COVID-19 pandemic caused many delays in cancer diagnosis, especially for at-risk groups. Researchers at Johns Hopkins are tracking 196 women to see if navigation improves follow-up rates within 30 days and reduces anxiety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Patient navigator support

What this could lead to

If effective, patient navigation could become a standard tool to reduce delays in breast cancer diagnosis, especially for vulnerable populations.

What could go wrong

This is a small, single-site study with no control group, so results may not apply broadly. The intervention is supportive, not a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins Breast Imaging clinics

    Baltimore, Maryland, 21093, United States